Mariana Herrera Diaz

[Rueda's Lab @lab_rueda]

🥳Today is a wonderful day for our laboratory. Dr. Mariana Herrera @mherrera15 was awarded with the @CIHR_IRSC REDI Early Career Transition Award @UofMMedMicro @umanitoba 🍁🇨🇴🇨🇦
Dr. Zulma Rueda is honored to be her supervisor 🥳
I love to celebrate my trainees' successes!!!

[Mariana Herrera Diaz @mherrera15]

10/10⬆️ IL-18 and MCP-1 were associated with a ⬇️risk of TB disease🫁. ⬆️sCD14 and TNF-a were associated with an ⬆️risk of TB disease.
Are you interested in these results and the new TB infections? You can contact @zulma_rueda @lab_rueda or me to talk about TB

[Mariana Herrera Diaz @mherrera15]

🧵1/10 We published a new paper in @FrontiersIn, and I want to share it with you. Let’s check the paper: https://t.co/ABCH60erhu

[Mariana Herrera Diaz @mherrera15]

9/10 🌟 Having a BCG scar was associated with ⬇️risk of a new TBI in people with SI. ⬆️MIP-3a was associated with a ⬆️risk of a new TBI. Compared to non-infected people, ⬆️Eotaxin was associated with a ⬇️risk of a new TBI in people with SI.

[Mariana Herrera Diaz @mherrera15]

8/10 🌟There were higher concentrations of sCD14 and TNF-a among people diagnosed with TB, MIP-3a among people with new TBI and short incarceration, and IL-18 and MCP-1 among people with new TBI and long incarceration

[Mariana Herrera Diaz @mherrera15]

8/10 B. There were higher⬆️ concentrations of sCD14 and TNF-a among people diagnosed with TB, MIP-3a among people with new TBI and short incarceration, and IL-18 and MCP-1 among people with new TBI and long incarceration

[Rueda's Lab @lab_rueda]

Please help us to share this information!
More information: https://t.co/YgLtynJunx

[Mariana Herrera Diaz @mherrera15]

12/12Conclusion The results from this study indicate that short-course treatment regimens such as 4 RMP and 3 3 HP can improve LTBI screening and treatment cascades in higher-risk populations. Follow us for more @Alltoge4ideas @lab_rueda @zulma_rueda @YoavKeynan

[Mariana Herrera Diaz @mherrera15]

@lab_rueda mentioned a tweetorial of our last paper published in @FrontPubHealth. Let's start 🧵https://t.co/lLQ0xz1Ndq

[Mariana Herrera Diaz @mherrera15]

11/12 The fact that most clients come from TB-endemic countries, have more knowledge of TB, and are likely to have known people who had TB disease, may contribute to their high treatment acceptance rate👏🏽👏🏽